US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Tharimmune Inc.

4.74

0.0000

Volume:- -

Turnover:- -

Market Cap:187.37M

PE:-1.21

High:4.74

Open:4.74

Low:4.74

Close:4.74

52wk High:9.08

52wk Low:0.9520

Shares:39.53M

Float Shares:35.11M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.9051

EPS(LYR):-9.4096

ROE:-225.01%

ROA:-99.79%

PB:30.44

PE(LYR):-0.50

Loading ...

Overview Company News Filings

Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering

THOMSON REUTERS

Tharimmune Inc - Issuance of 1,800,000 Shares at $2.92 per Share

THOMSON REUTERS

Tharimmune Faces Nasdaq Noncompliance Over Board Independence

BRIEF-Tharimmune Files For Mixed Shelf Of Up To $2.0 Bln - SEC Filing

Tharimmune files $2B mixed securities shelf

Tharimmune Raises $545 Million in Private Placement

Tharimmune Inc. Announces Date for Upcoming Special Stockholders Meeting

Tharimmune Inc. Appoints Jacob Asbury as Chief Financial Officer

Tharimmune Appoints Sireesh Appajosyula As Interim CFO On Nov 7 - SEC Filing

Tharimmune Inc. Files Initial Statement of Beneficial Ownership for President Mark Toomey

BUZZ-U.S. STOCKS ON THE MOVE-Broadwind, Verizon, APA

Tharimmune Shares Drop Premarket Following FDA Feedback on Plan for Lead Clinical Asset

BUZZ-Tharimmune rises after US FDA backs opioid overdose prevention drug plan

Tharimmune’s TH104 receives positive feedback from FDA

Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression From Fentanyl and Ultrapotent Opioids

THOMSON REUTERS

BRIEF-Tharimmune Appoints Sireesh Appajosyula As Interim CFO On Nov 7 - SEC Filing

Tharimmune Inc - on Nov 7, Appoints Sireesh Appajosyula as Interim CFO - SEC Filing

THOMSON REUTERS

Tharimmune Appoints Sireesh Appajosyula as Interim CFO

BRIEF-Tharimmune Entered ATM Sales Agreement Worth Up To $64.9 Million - SEC Filing

Tharimmune Inc - on Nov 6, Entered Atm Sales Agreement Worth up to $64.9 Mln - SEC Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/THAR/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"THAR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THAR\",,,,,undefined,":{"symbol":"THAR","market":"US","secType":"STK","nameCN":"Tharimmune Inc.","latestPrice":4.74,"timestamp":1772226000000,"preClose":4.74,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":35108800,"shares":39529800,"eps":-3.9051,"marketStatus":"Market Closed","change":0,"latestTime":"02-27 16:00:00 EST","open":4.74,"high":4.74,"low":4.74,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.9051,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772442000000},"marketStatusCode":7,"symbolChange":{"newSymbol":"CNTN","executeDate":"2026-02-18"},"adr":0,"listingDate":1641963600000,"exchange":"NASDAQ","adjPreClose":4.74,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THAR\",,,,,undefined,":{"symbol":"THAR","floatShares":35108800,"roa":"-99.79%","roe":"-225.01%","lyrEps":-9.409598,"shares":39529800,"dividePrice":0,"high":4.74,"amplitude":0,"preClose":4.74,"low":4.74,"week52Low":0.952,"pbRate":"30.44","week52High":9.08,"institutionHeld":0,"latestPrice":4.74,"eps":-3.9051,"divideRate":0,"volume":0,"delay":0,"ttmEps":-3.9051,"open":4.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/THAR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-18","symbol":"THAR","oldSymbol":"THAR","defaultRemindTime":1771425000000,"newSymbol":"CNTN","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1771390800000},{"market":"US","date":"2025-11-12","symbol":"THAR","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2025-08-14","symbol":"THAR","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.64},{"market":"US","date":"2025-03-25","symbol":"THAR","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742875200000,"reportTimeType":"post","actualEps":-2.02},{"market":"US","date":"2024-08-09","symbol":"THAR","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"","actualEps":-2.42}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"THAR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"THAR\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/THAR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"THAR","date":"2026-02-13","current":-1.213797,"percent":0.01426,"low":-20.992191,"twenty":-1.328706,"median":-0.366433,"eighty":-0.264359,"high":-0.078899,"avg":-1.70278,"sd":3.594431,"marketCap":169187745},"quantilePoints":[{"date":"2023-09-29","current":-0.382876,"twenty":-0.507054,"median":-0.396691,"eighty":-0.388402,"marketCap":3414917},{"date":"2023-10-05","current":-0.371034,"twenty":-0.396296,"median":-0.39077,"eighty":-0.38406,"marketCap":3309301},{"date":"2023-10-10","current":-0.365113,"twenty":-0.395507,"median":-0.388797,"eighty":-0.373639,"marketCap":3256493},{"date":"2023-10-19","current":-0.400638,"twenty":-0.396296,"median":-0.385837,"eighty":-0.371823,"marketCap":3573340},{"date":"2023-10-27","current":-0.354061,"twenty":-0.395901,"median":-0.382876,"eighty":-0.367481,"marketCap":3157918},{"date":"2023-11-02","current":-0.314984,"twenty":-0.394717,"median":-0.375178,"eighty":-0.354061,"marketCap":2809385},{"date":"2023-11-10","current":-0.37416,"twenty":-0.396691,"median":-0.374981,"eighty":-0.345575,"marketCap":3222178},{"date":"2023-11-17","current":-0.366027,"twenty":-0.394717,"median":-0.374571,"eighty":-0.354061,"marketCap":3152131},{"date":"2023-11-24","current":-0.23385,"twenty":-0.395112,"median":-0.373042,"eighty":-0.340009,"marketCap":2013859},{"date":"2023-12-01","current":-0.246337,"twenty":-0.391559,"median":-0.36684,"eighty":-0.303758,"marketCap":2121398},{"date":"2023-12-08","current":-0.177715,"twenty":-0.389586,"median":-0.365113,"eighty":-0.2671,"marketCap":1530437},{"date":"2023-12-15","current":-0.142524,"twenty":-0.386603,"median":-0.352622,"eighty":-0.21331,"marketCap":1227380},{"date":"2023-12-22","current":-0.155427,"twenty":-0.384688,"median":-0.345575,"eighty":-0.188612,"marketCap":1338501},{"date":"2023-12-29","current":-0.146629,"twenty":-0.383782,"median":-0.317747,"eighty":-0.176783,"marketCap":1262737},{"date":"2024-01-05","current":-0.146659,"twenty":-0.38276,"median":-0.312306,"eighty":-0.157175,"marketCap":1262989},{"date":"2024-01-12","current":-0.139005,"twenty":-0.38091,"median":-0.292008,"eighty":-0.148917,"marketCap":1197074},{"date":"2024-01-19","current":-0.114078,"twenty":-0.375376,"median":-0.280942,"eighty":-0.146629,"marketCap":982409},{"date":"2024-01-26","current":-0.133403,"twenty":-0.374981,"median":-0.23385,"eighty":-0.14311,"marketCap":1148838},{"date":"2024-02-02","current":-0.127861,"twenty":-0.37416,"median":-0.20534,"eighty":-0.138301,"marketCap":1101106},{"date":"2024-02-09","current":-0.111585,"twenty":-0.371924,"median":-0.18314,"eighty":-0.129796,"marketCap":960942},{"date":"2024-02-16","current":-0.114019,"twenty":-0.371034,"median":-0.158301,"eighty":-0.127861,"marketCap":981904},{"date":"2024-02-23","current":-0.111145,"twenty":-0.367679,"median":-0.155427,"eighty":-0.121656,"marketCap":957154},{"date":"2024-03-01","current":-0.48475,"twenty":-0.37506,"median":-0.166843,"eighty":-0.12223,"marketCap":4517427},{"date":"2024-03-08","current":-0.465853,"twenty":-0.385872,"median":-0.188565,"eighty":-0.123227,"marketCap":4341332},{"date":"2024-03-15","current":-0.464846,"twenty":-0.39748,"median":-0.211982,"eighty":-0.126981,"marketCap":4331940},{"date":"2024-03-22","current":-0.557437,"twenty":-0.450736,"median":-0.23385,"eighty":-0.128799,"marketCap":5194806},{"date":"2024-03-28","current":-0.547624,"twenty":-0.468827,"median":-0.280942,"eighty":-0.129034,"marketCap":5103356},{"date":"2024-04-05","current":-0.579242,"twenty":-0.47694,"median":-0.299351,"eighty":-0.129034,"marketCap":5398007},{"date":"2024-04-12","current":-0.522329,"twenty":-0.488151,"median":-0.314984,"eighty":-0.129491,"marketCap":4867635},{"date":"2024-04-19","current":-0.477811,"twenty":-0.486603,"median":-0.348379,"eighty":-0.13196,"marketCap":4452767},{"date":"2024-04-26","current":-0.45669,"twenty":-0.485414,"median":-0.359587,"eighty":-0.135532,"marketCap":4255940},{"date":"2024-05-03","current":-0.477432,"twenty":-0.482784,"median":-0.366433,"eighty":-0.137304,"marketCap":4449231},{"date":"2024-05-10","current":-0.518662,"twenty":-0.485414,"median":-0.371924,"eighty":-0.137996,"marketCap":4833456},{"date":"2024-05-17","current":-0.488448,"twenty":-0.487514,"median":-0.375178,"eighty":-0.138723,"marketCap":4340799},{"date":"2024-05-24","current":-0.434206,"twenty":-0.489085,"median":-0.382876,"eighty":-0.14006,"marketCap":3858750},{"date":"2024-05-31","current":-0.396974,"twenty":-0.487825,"median":-0.388797,"eighty":-0.141468,"marketCap":3527876},{"date":"2024-06-07","current":-0.451939,"twenty":-0.486699,"median":-0.395704,"eighty":-0.142758,"marketCap":4016347},{"date":"2024-06-14","current":-0.295417,"twenty":-0.486079,"median":-0.392744,"eighty":-0.143233,"marketCap":2625343},{"date":"2024-06-21","current":-0.276843,"twenty":-0.48475,"median":-0.386969,"eighty":-0.143726,"marketCap":2460277},{"date":"2024-06-28","current":-0.285687,"twenty":-0.484266,"median":-0.384008,"eighty":-0.144206,"marketCap":2538880},{"date":"2024-07-05","current":-0.293648,"twenty":-0.483128,"median":-0.378835,"eighty":-0.145162,"marketCap":2609622},{"date":"2024-07-12","current":-0.336103,"twenty":-0.481172,"median":-0.37416,"eighty":-0.146207,"marketCap":2986917},{"date":"2024-07-15","current":-0.339198,"twenty":-0.48087,"median":-0.373042,"eighty":-0.146313,"marketCap":3014428},{"date":"2024-08-02","current":-0.39802,"twenty":-0.480567,"median":-0.37416,"eighty":-0.146418,"marketCap":3537173},{"date":"2024-08-09","current":-0.357356,"twenty":-0.479583,"median":-0.371479,"eighty":-0.146647,"marketCap":3175790},{"date":"2024-08-16","current":-0.388311,"twenty":-0.47931,"median":-0.367704,"eighty":-0.147503,"marketCap":3446280},{"date":"2024-08-23","current":-0.383133,"twenty":-0.478979,"median":-0.3683,"eighty":-0.148084,"marketCap":3400329},{"date":"2024-08-30","current":-0.3621,"twenty":-0.478193,"median":-0.368895,"eighty":-0.150559,"marketCap":3213656},{"date":"2024-09-06","current":-0.374966,"twenty":-0.47771,"median":-0.368895,"eighty":-0.152319,"marketCap":3327842},{"date":"2024-09-13","current":-0.387016,"twenty":-0.477508,"median":-0.371479,"eighty":-0.153668,"marketCap":3434792},{"date":"2024-09-20","current":-0.387573,"twenty":-0.477179,"median":-0.37416,"eighty":-0.156013,"marketCap":3439732},{"date":"2024-09-27","current":-0.318415,"twenty":-0.476049,"median":-0.370611,"eighty":-0.157456,"marketCap":2825949},{"date":"2024-10-04","current":-0.288644,"twenty":-0.474874,"median":-0.368895,"eighty":-0.165134,"marketCap":2561734},{"date":"2024-10-11","current":-0.263637,"twenty":-0.474587,"median":-0.367652,"eighty":-0.176316,"marketCap":2339794},{"date":"2024-10-18","current":-0.304177,"twenty":-0.472752,"median":-0.367031,"eighty":-0.182055,"marketCap":2699586},{"date":"2024-10-25","current":-0.259599,"twenty":-0.469988,"median":-0.36557,"eighty":-0.188659,"marketCap":2303953},{"date":"2024-10-31","current":-0.443968,"twenty":-0.46923,"median":-0.363606,"eighty":-0.192108,"marketCap":3940246},{"date":"2024-11-08","current":-0.314532,"twenty":-0.469028,"median":-0.3621,"eighty":-0.207997,"marketCap":2791486},{"date":"2024-11-15","current":-0.305403,"twenty":-0.46859,"median":-0.361023,"eighty":-0.220423,"marketCap":3313862},{"date":"2024-11-22","current":-0.357444,"twenty":-0.468401,"median":-0.359587,"eighty":-0.228864,"marketCap":3878556},{"date":"2024-11-29","current":-0.28486,"twenty":-0.468199,"median":-0.357833,"eighty":-0.23385,"marketCap":3090956},{"date":"2024-12-06","current":-0.278012,"twenty":-0.466808,"median":-0.355708,"eighty":-0.23385,"marketCap":3016655},{"date":"2024-12-13","current":-0.298555,"twenty":-0.465853,"median":-0.352068,"eighty":-0.239263,"marketCap":3239560},{"date":"2024-12-20","current":-0.287599,"twenty":-0.465417,"median":-0.349391,"eighty":-0.246337,"marketCap":3120677},{"date":"2024-12-27","current":-0.294447,"twenty":-0.465417,"median":-0.343978,"eighty":-0.247606,"marketCap":3194979},{"date":"2025-01-03","current":-0.280751,"twenty":-0.465265,"median":-0.340267,"eighty":-0.248902,"marketCap":3046375},{"date":"2025-01-10","current":-0.297186,"twenty":-0.465036,"median":-0.335817,"eighty":-0.250096,"marketCap":3224700},{"date":"2025-01-17","current":-0.273904,"twenty":-0.46288,"median":-0.332711,"eighty":-0.251506,"marketCap":2972074},{"date":"2025-01-24","current":-0.295816,"twenty":-0.459788,"median":-0.324576,"eighty":-0.253179,"marketCap":3209839},{"date":"2025-01-31","current":-0.271165,"twenty":-0.458942,"median":-0.322298,"eighty":-0.256285,"marketCap":2942353},{"date":"2025-02-07","current":-0.367119,"twenty":-0.457712,"median":-0.324576,"eighty":-0.25649,"marketCap":3983531},{"date":"2025-02-14","current":-0.338605,"twenty":-0.457135,"median":-0.332752,"eighty":-0.257766,"marketCap":3674130},{"date":"2025-02-21","current":-0.332011,"twenty":-0.45669,"median":-0.334163,"eighty":-0.259599,"marketCap":3602581},{"date":"2025-02-28","current":-0.258409,"twenty":-0.45669,"median":-0.332711,"eighty":-0.258409,"marketCap":2803941},{"date":"2025-03-07","current":-0.279794,"twenty":-0.452773,"median":-0.327411,"eighty":-0.258409,"marketCap":3035992},{"date":"2025-03-14","current":-0.258409,"twenty":-0.451939,"median":-0.323592,"eighty":-0.257308,"marketCap":2803941},{"date":"2025-03-21","current":-0.27623,"twenty":-0.447209,"median":-0.318081,"eighty":-0.256285,"marketCap":2997317},{"date":"2025-03-28","current":-0.235121,"twenty":-0.446876,"median":-0.316359,"eighty":-0.256285,"marketCap":2867904},{"date":"2025-04-04","current":-0.216104,"twenty":-0.443968,"median":-0.314758,"eighty":-0.253062,"marketCap":2635941},{"date":"2025-04-11","current":-0.183256,"twenty":-0.434206,"median":-0.310649,"eighty":-0.250909,"marketCap":2235278},{"date":"2025-04-17","current":-0.190171,"twenty":-0.43272,"median":-0.309629,"eighty":-0.247606,"marketCap":2319628},{"date":"2025-04-25","current":-0.208324,"twenty":-0.428819,"median":-0.307528,"eighty":-0.235121,"marketCap":2541047},{"date":"2025-05-02","current":-0.267969,"twenty":-0.427212,"median":-0.306444,"eighty":-0.235121,"marketCap":3268567},{"date":"2025-05-09","current":-0.257596,"twenty":-0.421057,"median":-0.305275,"eighty":-0.235121,"marketCap":3142041},{"date":"2025-05-16","current":-0.223829,"twenty":-0.40927,"median":-0.304177,"eighty":-0.235121,"marketCap":2794097},{"date":"2025-05-23","current":-0.292009,"twenty":-0.404831,"median":-0.304105,"eighty":-0.236223,"marketCap":3645195},{"date":"2025-05-30","current":-0.315455,"twenty":-0.404174,"median":-0.304105,"eighty":-0.238157,"marketCap":3937875},{"date":"2025-06-06","current":-0.321849,"twenty":-0.402002,"median":-0.304798,"eighty":-0.241659,"marketCap":4017697},{"date":"2025-06-13","current":-0.292009,"twenty":-0.399067,"median":-0.305275,"eighty":-0.243561,"marketCap":3645195},{"date":"2025-06-20","current":-0.304798,"twenty":-0.397602,"median":-0.304972,"eighty":-0.244794,"marketCap":3804839},{"date":"2025-06-27","current":-0.375157,"twenty":-0.396861,"median":-0.305146,"eighty":-0.246971,"marketCap":4683145},{"date":"2025-07-03","current":-0.39645,"twenty":-0.396917,"median":-0.305471,"eighty":-0.248249,"marketCap":4948952},{"date":"2025-07-11","current":-0.5972,"twenty":-0.404301,"median":-0.306569,"eighty":-0.249668,"marketCap":7454942},{"date":"2025-07-18","current":-0.556712,"twenty":-0.425538,"median":-0.306929,"eighty":-0.250279,"marketCap":6949522},{"date":"2025-07-25","current":-0.516223,"twenty":-0.442016,"median":-0.309442,"eighty":-0.250983,"marketCap":6444102},{"date":"2025-08-01","current":-0.420971,"twenty":-0.447142,"median":-0.310453,"eighty":-0.25128,"marketCap":5255045},{"date":"2025-08-08","current":-0.426043,"twenty":-0.447142,"median":-0.313377,"eighty":-0.251504,"marketCap":5318359},{"date":"2025-08-15","current":-0.44633,"twenty":-0.447142,"median":-0.314989,"eighty":-0.252534,"marketCap":5571614},{"date":"2025-08-22","current":-1.917648,"twenty":-0.452606,"median":-0.315455,"eighty":-0.253419,"marketCap":23037197},{"date":"2025-08-29","current":-2.33436,"twenty":-0.457135,"median":-0.31712,"eighty":-0.254845,"marketCap":28043268},{"date":"2025-09-05","current":-1.53952,"twenty":-0.45993,"median":-0.318415,"eighty":-0.254845,"marketCap":18494651},{"date":"2025-09-12","current":-1.434614,"twenty":-0.465417,"median":-0.321839,"eighty":-0.255867,"marketCap":17234390},{"date":"2025-09-19","current":-1.219193,"twenty":-0.468452,"median":-0.32372,"eighty":-0.256285,"marketCap":14646478},{"date":"2025-09-26","current":-1.333779,"twenty":-0.470476,"median":-0.328904,"eighty":-0.256285,"marketCap":16023027},{"date":"2025-10-03","current":-1.397947,"twenty":-0.474798,"median":-0.332549,"eighty":-0.256627,"marketCap":16793894},{"date":"2025-10-10","current":-1.551156,"twenty":-0.477558,"median":-0.333715,"eighty":-0.256627,"marketCap":18634441},{"date":"2025-10-17","current":-1.415202,"twenty":-0.479329,"median":-0.335938,"eighty":-0.257308,"marketCap":17001190},{"date":"2025-10-24","current":-1.42503,"twenty":-0.48475,"median":-0.336823,"eighty":-0.257596,"marketCap":17119253},{"date":"2025-10-31","current":-1.459427,"twenty":-0.49004,"median":-0.338605,"eighty":-0.258409,"marketCap":17532477},{"date":"2025-11-07","current":-2.039267,"twenty":-0.497599,"median":-0.338753,"eighty":-0.258409,"marketCap":24498242},{"date":"2025-11-14","current":-8.65895,"twenty":-0.503898,"median":-0.340387,"eighty":-0.258409,"marketCap":104022204},{"date":"2025-11-21","current":-7.641143,"twenty":-0.517755,"median":-0.341858,"eighty":-0.258409,"marketCap":78850827},{"date":"2025-11-28","current":-8.829765,"twenty":-0.519395,"median":-0.344763,"eighty":-0.259361,"marketCap":91116511},{"date":"2025-12-05","current":-8.388277,"twenty":-0.533762,"median":-0.349297,"eighty":-0.260073,"marketCap":86560685},{"date":"2025-12-12","current":-8.592041,"twenty":-0.548092,"median":-0.351131,"eighty":-0.260881,"marketCap":88663374},{"date":"2025-12-19","current":-7.539261,"twenty":-0.556524,"median":-0.352716,"eighty":-0.261381,"marketCap":77799482},{"date":"2025-12-26","current":-8.693923,"twenty":-0.560626,"median":-0.354061,"eighty":-0.261935,"marketCap":89714718},{"date":"2026-01-02","current":-10.290073,"twenty":-0.564346,"median":-0.356426,"eighty":-0.262452,"marketCap":106185780},{"date":"2026-01-09","current":-10.277334,"twenty":-0.570228,"median":-0.357638,"eighty":-0.262757,"marketCap":106054324},{"date":"2026-01-16","current":-10.723933,"twenty":-0.586339,"median":-0.359587,"eighty":-0.263065,"marketCap":110662897},{"date":"2026-01-23","current":-11.530382,"twenty":-0.593826,"median":-0.360171,"eighty":-0.263549,"marketCap":118984839},{"date":"2026-01-30","current":-17.123192,"twenty":-1.128981,"median":-0.361332,"eighty":-0.263661,"marketCap":176698416},{"date":"2026-02-06","current":-15.054619,"twenty":-1.279694,"median":-0.362423,"eighty":-0.263867,"marketCap":155352298},{"date":"2026-02-13","current":-16.395361,"twenty":-1.328706,"median":-0.366433,"eighty":-0.264359,"marketCap":169187745}],"updateTime":1772367172914},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"THAR\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2604169481","title":"Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2604169481","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604169481?lang=en_us&edition=fundamental","pubTime":"2026-01-20 21:45","pubTimestamp":1768916700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUA6GPJSK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2604116152","title":"Tharimmune Inc - Issuance of 1,800,000 Shares at $2.92 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2604116152","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604116152?lang=en_us&edition=fundamental","pubTime":"2026-01-20 21:45","pubTimestamp":1768916700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUA6GPJSK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2603393513","title":"Tharimmune Faces Nasdaq Noncompliance Over Board Independence","url":"https://stock-news.laohu8.com/highlight/detail?id=2603393513","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603393513?lang=en_us&edition=fundamental","pubTime":"2026-01-16 05:11","pubTimestamp":1768511497,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. has received a notification from the Nasdaq Stock Market regarding its failure to comply with Nasdaq Listing Rule 5605, which mandates that a majority of the company's Board of Directors be independent. The noncompliance followed recent board resignations, resulting in the company lacking the required number of independent directors. Nasdaq has granted Tharimmune a cure period, giving the company until its next annual shareholders' meeting or November 6, 2026, to regain compliance. Tharimmune plans to address the issue by seeking shareholder approval to elect two additional independent directors at a special meeting scheduled for January 30, 2026, which is expected to restore compliance with the listing requirements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interprete","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDLxz35v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2602302546","title":"BRIEF-Tharimmune Files For Mixed Shelf Of Up To $2.0 Bln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2602302546","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602302546?lang=en_us&edition=fundamental","pubTime":"2026-01-10 06:51","pubTimestamp":1767999113,"startTime":"0","endTime":"0","summary":"BRIEF-Tharimmune Files For Mixed Shelf Of Up To $2.0 Bln - SEC FilingJan 9 (Reuters) - Tharimmune Inc THAR.O:THARIMMUNE INC FILES FOR MIXED SHELF OF UP TO $2.0 BILLION - SEC FILINGSource text: [ID:n0001493152-26-001115]Further company coverage: THAR.O ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA1MT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2602230453","title":"Tharimmune files $2B mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2602230453","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602230453?lang=en_us&edition=fundamental","pubTime":"2026-01-10 05:40","pubTimestamp":1767994832,"startTime":"0","endTime":"0","summary":"16:35 EST Tharimmune (THAR) files $2B mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tharimmune-files-2b-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tharimmune-files-2b-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2592906234","title":"Tharimmune Raises $545 Million in Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2592906234","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592906234?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:15","pubTimestamp":1766063725,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. established its digital asset treasury strategy in November 2025 with a $545 million private placement. The proceeds from this unregistered sale of shares are intended to support the expansion and long-term ecosystem development of the Canton Network, including the acquisition of Canton Coin and deeper integration within the network's infrastructure.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via PR Newswire  on December 18, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL3xqbzT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2592493709","title":"Tharimmune Inc. Announces Date for Upcoming Special Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2592493709","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592493709?lang=en_us&edition=fundamental","pubTime":"2025-12-17 05:21","pubTimestamp":1765920087,"startTime":"0","endTime":"0","summary":"Tharimmune, Inc. has announced that it will hold a special meeting of stockholders on January 22, 2026. During the meeting, stockholders will be asked to vote on several proposals, including the election of two new directors to the Board, the approval of the issuance of shares of common stock upon the exercise of Strategic Advisor Warrants, the approval of the issuance of shares of common stock upon the exercise of Cryptocurrency Pre-Funded Warrants, an amendment to the 2023 Equity Incentive Plan, and the potential adjournment of the special meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL4d42W3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2590097955","title":"Tharimmune Inc. Appoints Jacob Asbury as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2590097955","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590097955?lang=en_us&edition=fundamental","pubTime":"2025-12-12 21:15","pubTimestamp":1765545333,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. has appointed Jacob Asbury as Chief Financial Officer. Asbury will oversee financial strategy and operations, including capital planning, treasury management, and the development of the company's digital asset treasury infrastructure. He joins Tharimmune with extensive experience in capital markets and fintech, having previously served as CFO of Clear Street Group and held similar roles at other firms.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via Business Wire  on December 12, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDLbT8J0l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2584993921","title":"Tharimmune Appoints Sireesh Appajosyula As Interim CFO On Nov 7 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584993921","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584993921?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:15","pubTimestamp":1763572557,"startTime":"0","endTime":"0","summary":"Nov 11 (Reuters) - Tharimmune Inc ::*THARIMMUNE INC - ON NOV 7, APPOINTS SIREESH APPAJOSYULA AS INTERIM CFO - SEC FILING  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 10-NOV-202522:44:16 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD1zQwny:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2583686460","title":"Tharimmune Inc. Files Initial Statement of Beneficial Ownership for President Mark Toomey","url":"https://stock-news.laohu8.com/highlight/detail?id=2583686460","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583686460?lang=en_us&edition=fundamental","pubTime":"2025-11-15 03:19","pubTimestamp":1763147950,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing names Mark Christopher Toomey as the beneficial owner, who serves as President of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL1DFMJl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2583515940","title":"BUZZ-U.S. STOCKS ON THE MOVE-Broadwind, Verizon, APA","url":"https://stock-news.laohu8.com/highlight/detail?id=2583515940","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583515940?lang=en_us&edition=fundamental","pubTime":"2025-11-14 03:09","pubTimestamp":1763060958,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Broadwind, Verizon, APAEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL6N3WP0NC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARDT","IE0009355771.USD","LU2458330243.SGD","SSYS","HL","LU0234572021.USD","SCVL","SG","NEM","AMAT","SPB","MRSN","FLY","MRK","SBH","SEE","IONS","ALB","SLB","VZ","IMRX","APA","CLBT","CDE","KURA","CTEV","ANNX","CTRI","EPC","XNET","MGRX","PSFE","BWEN","CVX","DASH","BR","BTDR","THAR","HZO","DDS","HAL"],"gpt_icon":1},{"id":"2583596288","title":"Tharimmune Shares Drop Premarket Following FDA Feedback on Plan for Lead Clinical Asset","url":"https://stock-news.laohu8.com/highlight/detail?id=2583596288","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583596288?lang=en_us&edition=fundamental","pubTime":"2025-11-13 22:23","pubTimestamp":1763043780,"startTime":"0","endTime":"0","summary":"Tharimmune's shares were under pressure Thursday despite the company's lead clinical asset receiving what it said was positive feedback from the Food and Drug Administration on a simulation modeling plan.In premarket trading, the shares were down 6% after climbing sharply earlier in the morning. The stock has climbed almost 60% this year, last closing at $3.22.Tharimmune said the FDA following a review concurred with its proposed modeling plan for its TH104 nalmefene buccal film opioid treatment, and provided guidance on specific technical elements that the company plans to integrate into the finalized modeling.It said the FDA's feedback further de-risks the TH104 program.Tharimmune said it presented its initial pharmacokinetic simulation results and a plan for a more detailed pharmacokinetic modeling for FDA review. The modeling plan represents a critical component in advancing TH104 as a prophylactic countermeasure to mitigate respiratory depression caused by fentanyl and other ultra","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2583459369","title":"BUZZ-Tharimmune rises after US FDA backs opioid overdose prevention drug plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2583459369","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583459369?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:38","pubTimestamp":1763041093,"startTime":"0","endTime":"0","summary":"BUZZ-Tharimmune rises after US FDA backs opioid overdose prevention drug plan** Shares of drug-developer Tharimmune THAR.O rise 1.58% to $3.24 premarket** Co says it receives positive feedback from the U.S. FDA for its experimental drug TH104, designed to prevent breathing problems caused by fentanyl and other powerful opioids** The FDA agrees with co's plan to use computer modeling to show how the drug works in the body and offers technical advice to improve the study - THAR** Co's TH104 is a thin film that dissolves in the mouth, designed for easy use by first responders or military personnel exposed to dangerous opioids - THAR** Co simulations show TH104 starts working in 30 min and protects for 24 hrs vs naloxone's <2 hrs** Up to last close, stock up ~59% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL4N3WP0ZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2583598265","title":"Tharimmune’s TH104 receives positive feedback from FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2583598265","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583598265?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:10","pubTimestamp":1763039459,"startTime":"0","endTime":"0","summary":"Tharimmune (THAR) announced an update from the biotechnology side of the business. Its lead clinical asset, TH104, received positive feedback from ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tharimmunes-th104-receives-positive-feedback-from-fda-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tharimmunes-th104-receives-positive-feedback-from-fda-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2583871598","title":"Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression From Fentanyl and Ultrapotent Opioids","url":"https://stock-news.laohu8.com/highlight/detail?id=2583871598","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583871598?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:05","pubTimestamp":1763039100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nTUA46YXYY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2582491386","title":"BRIEF-Tharimmune Appoints Sireesh Appajosyula As Interim CFO On Nov 7 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2582491386","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582491386?lang=en_us&edition=fundamental","pubTime":"2025-11-11 06:44","pubTimestamp":1762814656,"startTime":"0","endTime":"0","summary":"BRIEF-Tharimmune Appoints Sireesh Appajosyula As Interim CFO On Nov 7 - SEC FilingNov 11  - Tharimmune Inc THAR.O:THARIMMUNE INC - ON NOV 7, APPOINTS SIREESH APPAJOSYULA AS INTERIM CFO - SEC FILINGSource text: [ID:n0001493152-25-021577]Further company coverage: THAR.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nFWN3WM21L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2582386664","title":"Tharimmune Inc - on Nov 7, Appoints Sireesh Appajosyula as Interim CFO - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2582386664","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582386664?lang=en_us&edition=fundamental","pubTime":"2025-11-11 06:36","pubTimestamp":1762814193,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nFWN3WM21L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2582438655","title":"Tharimmune Appoints Sireesh Appajosyula as Interim CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2582438655","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582438655?lang=en_us&edition=fundamental","pubTime":"2025-11-11 06:31","pubTimestamp":1762813903,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. has announced the appointment of Sireesh Appajosyula as interim Chief Financial Officer. His term will run until December 31, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL8btm5Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2581001206","title":"BRIEF-Tharimmune Entered ATM Sales Agreement Worth Up To $64.9 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581001206","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581001206?lang=en_us&edition=fundamental","pubTime":"2025-11-07 19:28","pubTimestamp":1762514900,"startTime":"0","endTime":"0","summary":"BRIEF-Tharimmune Entered ATM Sales Agreement Worth Up To $64.9 Million - SEC FilingNov 7  - Tharimmune Inc THAR.O:THARIMMUNE INC - ON NOV 6, ENTERED ATM SALES AGREEMENT WORTH UP TO $64.9 MILLION - SEC FILINGSource text: [ID:n0001493152-25-021152]Further company coverage: THAR.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nFWN3WJ0FL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2581001696","title":"Tharimmune Inc - on Nov 6, Entered Atm Sales Agreement Worth up to $64.9 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581001696","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581001696?lang=en_us&edition=fundamental","pubTime":"2025-11-07 19:17","pubTimestamp":1762514241,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nFWN3WJ0FL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","THAR"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":58,"code":"91000000","status":"200"}]}}